子類別 會議論文/會議摘要 [2/2] 期刊論文 [137/139] 鄰近社群 余佳益 [17/17] 余冠儀 [40/40] 冷治湘 [61/89] 劉士任 [121/149] 劉家齊 [45/52] 司徒惠康 [71/72] 吳綺容 [84/84] 周彥宏 [46/58] 宋旺洲 [33/34] 廖經倫 [32/32] 張仲明 [2/2] 張堯 [44/44] 曾凡真 [34/34] 曾才騰 [9/9] 李敏西 [60/64] 杜鴻運 [50/50] 楊采菱 [133/134] 潘建雄 [18/19] 羅秀容 [96/97] 胡勇誌 [23/23] 莊再成 [104/153] 蕭樑基 [158/161] 蘇益仁(2002-2015) [190/195] 許修誌(2005-2010) [1/1] 許素菁 [27/30] 謝鐸源(2006-2014) [20/27] 陳俊宏 [61/62] 陳信偉 [83/110] 陳宜君 [38/38] 陳逢叡 [40/40] 黃明熙 [51/64] 黃盈綺 [6/6] 齊嘉鈺 [46/46] McDonald LC(1998-2000) [12/12] 何曼德(1997-2002) [38/39] 其他 [177/177] 朱清良(2005-2007) [4/4] 梁蘭蘭(1998-2006) [6/6] 黃崑巖(1999-2004) [4/4] 社群統計 近3年內發表的文件:13(9.22%) 含全文筆數:139(98.58%) 文件下載次數統計 下載大於0次:139(100.00%) 下載大於100次:135(97.12%) 檔案下載總次數:54887(1.02%) 最後更新時間: 2024-12-01 03:13 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Clonal expansion of Tn1546-like tra... Changing epidemiology and antimicro... Imipenem reduces the efficacy of va... The individual contributions of bla... Elizabethkingia anophelis outer mem... In vitro and in vivo evidence disco... High-level levofloxacin-resistant e... Contribution of testing strategies ... Biofilm formation is not an indepen... Discrimination of methicillin-resis...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 141. (共6頁) 1 2 3 4 5 6 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2024-08-06	Changing epidemiology and antimicrobial resistance of bacteria causing bacteremia in Taiwan: 2002-2020	Microbiology Spectrum. 2024 Aug 6;12(8):Article number e0060824.
2024-08	Imipenem reduces the efficacy of vancomycin against Elizabethkingia species	Journal of Antimicrobial Chemotherapy. 2024 Aug 1;79(8):2048-2052.
2024-07-10	Clonal expansion of Tn1546-like transposon-carrying vancomycin-resistant Enterococcus faecium, a nationwide study in Taiwan, 2004-2018	Journal of Global Antimicrobial Resistance. 2024 Jul 10;39:100-108.
2024-07	The individual contributions of blaB, blaGOB and blaCME on MICs of Beta-lactams in Elizabethkingia anophelis	Journal of Antimicrobial Chemotherapy. 2024 Jul;79(7):1577-1580.
2024-01	In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species	Journal of Antimicrobial Chemotherapy. 2024 Jan 3;79(1):200-202
2023-11-28	Elizabethkingia anophelis outer membrane vesicles as a novel vaccine candidate against infection: Insights into immune response and potential for passive immunity	mSphere. 2023 Nov 28;Article number e0040023.
2023-08	High-level levofloxacin-resistant emm12 group A Streptococcus, 2012–2018: A multicenter study in Taiwan	Journal of Microbiology, Immunology and Infection. 2023 Aug;56(4):875-879.
2022-11	Contribution of testing strategies and contact tracing towards COVID-19 outbreaks control: A mathematical modeling study	Tropical Medicine and Infectious Disease. 2022 Nov;7(11):Article number 376.
2022-09-16	Biofilm formation is not an independent risk factor for mortality in patients with Acinetobacter baumannii bacteremia	Frontiers in Cellular and Infection Microbiology. 2022 Sep 16;12:Article number 964539.
2022-05-25	A comprehensive evaluation of COVID-19 policies and outcomes in 50 countries and territories	Scientific Reports. 2022 May 25;12:Article number 8802.
2022-05-16	Discrimination of methicillin-resistant staphylococcus aureus by MALDI-TOF mass spectrometry with machine learning techniques in patients with staphylococcus aureus bacteremia	Pathogens. 2022 May 16;11(5):Article number 586.
2022-05-01	In vitro and in vivo comparison of eravacycline- and tigecycline-based combination therapies for tigecycline-resistant Acinetobacter baumannii	Journal of Chemotherapy. 2022 May 01;34(3):166-172.
2022-04	The prediction values of carbapenemase detection methods and carbapenem susceptibility testing for clinical outcomes of patients with Acinetobacter bacteremia under carbapenem treatment	Journal of Microbiology, Immunology and Infection. 2022 Apr;55(2):257-265.
2021-08-06	In vitro activity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan	Journal of Antimicrobial Chemotherapy. 2021 Aug 6;76(8):2071-2078.
2021-08	Mobile resistomes of human pathogens in swine wastewater treatment plants	Journal of Microbiology, Immunology, and Infection. 2021 Aug;54(4):752-754.
2021-06-14	Antimicrobial resistance mechanisms and virulence of colistin-and carbapenem-resistant acinetobacter baumannii isolated from a teaching hospital in Taiwan	Microorganisms. 2021 Jun 14;9(6):Article number 1295.
2021-04-13	Multicentre study of risk factors for mortality in patients with acinetobacter bacteraemia receiving colistin treatment[Erratum:International Journal of Antimicrobial Agents. 2020 Jun;55(6):Article number 105956.]	International Journal of Antimicrobial Agents. 2021 Apr 13;57(5):Article number 106333.
2021-03	Susceptibility of Elizabethkingia spp. to commonly tested and novel antibiotics and concordance between broth microdilution and automated testing methods	Journal of Antimicrobial Chemotherapy. 2021 Mar;76(3):653-658.
2021-02	Emergence of mcr-1, mcr-3, and mcr-8 in clinical Klebsiella pneumoniae isolates in Taiwan	Clinical Microbiology and Infection. 2021 Feb;27(2):305-307.
2021-02	In vitro and in vivo activities of imipenem combined with BLI-489 against class D Beta-lactamase-producing Acinetobacter baumannii	Journal of Antimicrobial Chemotherapy. 2021 Feb;76(2):451-459.
2021-02	Clinical and molecular characterization of Acinetobacter seifertii in Taiwan	Journal of Antimicrobial Chemotherapy. 2021 Feb;76(2):312-321.
2021-01	Nonpolio enterovirus activity during the COVID-19 pandemic, Taiwan, 2020	Emerging Infectious Diseases. 2021 Jan;27(1):306-308.
2021-01	Ser253Leu substitution in PmrB contributes to colistin resistance in clinical Acinetobacter nosocomialis	Emerging Microbes and Infections. 2021 Jan;10(1):1873-1880.
2020-11-26	Clinical and economic impact of intensive care unit-acquired bloodstream infections in Taiwan: A nationwide population-based retrospective cohort study	BMJ Open. 2020 Nov 26;10(11):Article number e037484.
2020-10	Increased mcr-1 in pathogenic Escherichia coli from diseased swine, Taiwan	Journal of Microbiology, Immunology and Infection. 2020 Oct;53(5):751-756.

顯示項目1-25 / 141. (共6頁) 1 2 3 4 5 6 > >> 每頁顯示[10|25|50]項目